Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • leekb
    Junior Member
    • Jul 2013
    • 7

    FastQC Report: A horn in Per sequence GC content ?!

    Hi Everyone,

    Nice to meet you guys here!
    I'm doing ChIP-Seq using HiSeq 1500 on SR 50 cycles, multiplexed condition.
    And I got a funny curve in my FastQC report on Per sequence GC content and Sequence Duplication Levels as well as overrepresented sequence.
    Anyone please give a help
    1) Why my Per sequence GC content curve got a horn?
    2) How come such high sequence duplication level like 71.09% ? Due to overrepresented sequence?
    3) As attached BioAnalyzer, there's totally absence of adapter, why still overrepresented sequence like Index 7?

    Library prep condition: 12cycles PCR amplification

    Cheers!
    kb
    Attached Files
  • leekb
    Junior Member
    • Jul 2013
    • 7

    #2
    One more strange FastQC report

    Originally posted by leekb View Post
    Hi Everyone,

    Nice to meet you guys here!
    I'm doing ChIP-Seq using HiSeq 1500 on SR 50 cycles, multiplexed condition.
    And I got a funny curve in my FastQC report on Per sequence GC content and Sequence Duplication Levels as well as overrepresented sequence.
    Anyone please give a help
    1) Why my Per sequence GC content curve got a horn?
    2) How come such high sequence duplication level like 71.09% ? Due to overrepresented sequence?
    3) As attached BioAnalyzer, there's totally absence of adapter, why still overrepresented sequence like Index 7?

    Library prep condition: 12cycles PCR amplification

    Cheers!
    kb
    Hi all,

    More strange FastQC report.
    This's time I got problems on
    1)Per base sequence quality: why quality drop dramatically in base 23-25? Is there a bubble inside the lane?
    2)per base N content : a small peak shows up in base 23, any relationship with quality drop in per base sequence result?
    3)sequence duplication levels : a little bit difference from above one, but more serious in duplication.

    In general, is't a fair good result or in very pool quality? Should I keep continue the analysis?

    kb
    Attached Files

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #3
      Originally posted by leekb View Post
      Hi all,

      More strange FastQC report.
      This's time I got problems on
      1)Per base sequence quality: why quality drop dramatically in base 23-25? Is there a bubble inside the lane?
      2)per base N content : a small peak shows up in base 23, any relationship with quality drop in per base sequence result?
      3)sequence duplication levels : a little bit difference from above one, but more serious in duplication.

      In general, is't a fair good result or in very pool quality? Should I keep continue the analysis?

      kb
      It is possible that there was a bubble in the lane (or some other issue) around cycle 23. It does not appear to be a severe problem though since most of bases are still appear to be of good quality. Hopefully during alignment these reads would not align and will be discarded.

      Since you are doing ChIP-seq you may be enriching a binding sequence that may have a GC predominance. You should continue with the analysis.

      Just to be safe run your sequences through "trimmomatic" (http://www.usadellab.org/cms/?page=trimmomatic) to make sure that there are no primer dimer and other odd contaminants.
      Last edited by GenoMax; 10-23-2013, 03:28 AM.

      Comment

      • leekb
        Junior Member
        • Jul 2013
        • 7

        #4
        Originally posted by GenoMax View Post
        It is possible that there was a bubble in the lane (or some other issue) around cycle 23. It does not appear to be a severe problem though since most of bases are still appear to be of good quality. Hopefully during alignment these reads would not align and will be discarded.

        Since you are doing ChIP-seq you may be enriching a binding sequence that may have a GC predominance. You should continue with the analysis.

        Just to be safe run your sequences through "trimmomatic" (http://www.usadellab.org/cms/?page=trimmomatic) to make sure that there are no primer dimer and other odd contaminants.
        Thanks GenoMax!

        Yes you're right, though cycle 23-25 drop quality but still stays in green zone.

        How about my duplication levels issue? It's crazy high and looks like not much unique reads left for me to analysis. Any way to improve next time?
        Many thanks!

        kb

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        38 views
        0 reactions
        Last Post SEQadmin2  
        Working...